Source: Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128 Key Points Question Is high-dose (>12 mg) buprenorphine induction safe and...

Source: Hser, YI., Ober, A.J., Dopp, A.R. et al. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial. Addict Sci Clin Pract 16, 24 (2021)...

Source: Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9 Abstract Background Patients with opioid use disorder...

Source: Kelley, A.T., Smid, M.C., Baylis, J.D. et al. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addict Sci Clin Pract 16, 40 (2021). https://doi.org/10.1186/s13722-021-00246-6 Abstract...

Source: Garland, E. L., Atchley, R. M., Hanley, A. W., Zubieta, J. K., & Froeliger, B. (2019). Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Science advances, 5(10), eaax1569. Abstract Addiction...

Source: Lintzeris N, Dunlop AJ, Haber PS, et al. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(5):e219041. doi:10.1001/jamanetworkopen.2021.9041 Key Points...

Source: Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021-00378-7 Abstract Background A lack of conceptual modeling of...

Los medicamentos para la sobredosis, la abstinencia y la adicción a los opioides Esta infografía ilustra los distintos tipos de medicamentos que se recetan para la sobredosis, la abstinencia y la adicción a los opioides. Medicamentos para la sobredosis, la abstinencia y la adicción a los opioides...

Medications for Opioid Use Disorder Infographic This infographic shows the different types of medications prescribed for opioid overdose, withdrawal, and addiction. Medications for opioid overdose, withdrawal, and addiction Medications for opioid overdose, withdrawal, and addiction are safe...

Fuente: Cruz Martín del Campo SL, Rivera García MT. Las nuevas drogas: origen, mecanismos de acción y efectos. Una revisión de la literatura. RIIAD [Internet]. 1ene.2015 Resumen Introducción: existen en el mercado sustancias psicoactivas de reciente aparición que se conocen genéricamente como nuevas...

Source: Tai, B., Dobbins, R., Blackeney, Q. et al. The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic. Addict Sci Clin Pract 16, 28 (2021). https://doi.org/10.1186/s13722-021-00238-6 Abstract Over the past two decades, the National Drug Abuse Treatment Clinical...

Source: Wen X, Belviso N, Murray E, Lewkowitz AK, Ward KE, Meador KJ. Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations. JAMA Netw Open. 2021;4(4):e215708. doi:10.1001/jamanetworkopen.2021.5708 Key Points Question Is there an association between prenatal...

Source: Ford, B. R., Bart, G., Grahan, B., Shearer, R. D., & Winkelman, T. N. (2020). Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder. Journal of Addiction Medicine. Abstract Objective: To examine...

Source: Warren EC, Kolodny A. Trends in Heroin Treatment Admissions in the United States by Race, Sex, and Age. JAMA Netw Open. 2021;4(2):e2036640. doi:10.1001/jamanetworkopen.2020.36640 This study’s results suggest important differences in heroin treatment admissions to state-regulated programs by...

Source: Linas BP, Savinkina A, Madushani RWMA, et al. Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Netw Open. 2021;4(2):e2037259. doi:10.1001/jamanetworkopen.2020.37259 Key Points Question Using simulated urban and rural communities, what evidence-based practices...

Fuente: https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP20-05-02-003%20PDF_508.pdf Esta publicación presenta datos recientes sobre la prevalencia del uso indebido de opioides y las tasas de mortalidad en la población hispana / latina, los factores contextuales y los desafíos...

Source: Courser, M. W., & Raffle, H. (2021). With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 122, 108220. Highlights •It is important to consider the needs of people...

Source: Khan, A., Khan, Q., & Kolb, E. (2021). Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes. Journal of Substance Abuse Treatment, 123, 108256. Highlights •Provision of buprenorphine at scheduled clinic visits as opposed to filling...

Source: Figgatt, M. C., Salazar, Z., Day, E., Vincent, L., & Dasgupta, N. (2021). Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. Journal of Substance Abuse Treatment, 123, 108276. Highlights •Methadone take-home dosing of survey participants...

Source: Xu KY, Presnall N, Mintz CM, et al. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events. JAMA Netw Open. 2021;4(2):e210061. doi:10.1001/jamanetworkopen.2021.0061 Key Points Question Are opioid use disorder (OUD) medications associated with alcohol-related...